Respiratory Syncytial Virus in Older Adults: Burden, Diagnosis, and Prevention Strategies for Primary Care

0.75 CME
0.75 CNE
45 MINS
$0 FEE
SAVE
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Respiratory Syncytial Virus in Older Adults: Burden, Diagnosis, and Prevention Strategies for Primary Care

Overview

Provider Statement

This continuing education activity is provided by Vindico Medical Education


Support Statement

This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP.

There is no non-commercial support for this activity.

Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply ANCC Commission on Accreditation endorsement of any commercial products.


Activity Description

Respiratory syncytial virus (RSV) is a highly prevalent, contagious respiratory infection and a leading cause of bronchitis and pneumonia. Although most cases manifest clinically as mild to moderate upper respiratory disease, severe sequelae can occur. RSV infections can be dangerous for elderly and high-risk adults, leading to complications such as pneumonia, worsening of preexisting pulmonary conditions, and congestive heart failure. In this activity, experts will examine the burden of RSV infection in older adults, including risk factors for severe disease. Faculty will review diagnostic challenges and criteria for detecting RSV, as well as outline strategies preventing RSV in older adults—highlighting recent evidence for vaccines in late-stage development.


Target Audience

The intended audience for this activity is family medicine physicians, nurses, internists, nurse practitioners, physician assistants, and other health care professionals involved in the management of patients with or at risk for RSV.


Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Examine the burden and complications of respiratory syncytial virus (RSV) infection in older adults, including the risk factors for the development of severe disease.
  • Describe the diagnostic challenges and criteria for the detection of RSV.
  • Review strategies for the prevention of RSV, including recent evidence for vaccines in development.

Activity Chair

Charles P. Vega, MD, FAAFP
Health Sciences Clinical Professor, Department of Family Medicine
Director, Program in Medical Education for the Latino Community
Assistant Dean for Culture and Community Education
University of California, Irvine
Irvine, CA


Faculty

William Greendyke, MD, IDSA, SHEA
Assistant Professor of Medicine
Columbia University Irving Medical Center
New York, NY

Shmuel Shoham, MD, FACP, FIDSA, FAST
Professor of Medicine, Johns Hopkins University School of Medicine
Baltimore, MD


Planners/Reviewers

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Barbara A. Niedz, PhD, RN, CPHQ


Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Vindico Medical Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center (ANCC) Commission on Accreditation.


Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

abimSuccessful completion of this CME activity enables the participant to earn up to 0.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participants who opt-in by providing their ABIM ID and DOB (MM/DD) will earn MOC points equivalent to the amount of CME credits claimed for the activity.

Vindico Medical Education will provide a maximum of 0.75 contact hours for nurses. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners Certification Board (AANPCB). AANPCB will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME.

American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 0.75 hours credit for completing this program.

This enduring material is approved for 1 year from the date of original release, June 20, 2022, to June 19, 2023.


How to Participate in This Activity and Obtain CE Credit

To participate in this CE activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 of the 4 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate or Contact Hour certificate.


Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Relationship information is accurate at the time of content development.

Activity Chair and Faculty report the following relevant relationship(s)

William Greendyke, MD, IDSA, SHEA
No relevant financial relationships to disclose.

Shmuel Shoham, MD, FACP, FIDSA, FAST
Consultant: Karyopharm

Charles P. Vega, MD, FAAFP
Consultant: GlaxoSmithKline, Johnson & Johnson

Planners/Reviewers report the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP; and Barbara A. Niedz, PhD, RN, CPHQ
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.


Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.


Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2022 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.


CE Questions?

Contact us at cme@vindicoCME.com